Outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating women
The problem of treating the new coronavirus infection COVID-19 in pregnant and lactating women is an urgent problem of world health. According to foreign authors (Mantlo E., Bukreyeva N., Maruyama J., Paessler S., Huang C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antiviral...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849248478636539904 |
|---|---|
| author | A. V. Mordyk L. V. Puzyreva K. Yu. Samsonov N. V. Bagisheva |
| author_facet | A. V. Mordyk L. V. Puzyreva K. Yu. Samsonov N. V. Bagisheva |
| author_sort | A. V. Mordyk |
| collection | DOAJ |
| description | The problem of treating the new coronavirus infection COVID-19 in pregnant and lactating women is an urgent problem of world health. According to foreign authors (Mantlo E., Bukreyeva N., Maruyama J., Paessler S., Huang C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antiviral Res. 2020 Jul; 179: 104811) recombinant interferon α is active against the novel coronavirus in vitro in the cell culture model Vero and SARS-CoV-2 (COVID-19). SARS-CoV-2 (COVID-19) is sensitive to recombinant interferon α-2b, but high serum concentrations (more than 300 IU / ml) are required to achieve a therapeutic effect, which are achieved with systemic administration of more than 3,000,000 IU of recombinant interferon α -2b. The article analyzes the clinical symptoms and the effectiveness of therapy for the new coronavirus infection COVID-19 in pregnant and lactating women in outpatient practice with high doses of interferon α-2b (by the decision of the council of doctors). The authors found that complex therapy with high doses of interferon α-2b infection COVID-19 in pregnant women flows relatively favorably and ends with recovery. In lactating women who do not work because of parental leave, the new coronavirus infection had mild clinical symptoms and was accompanied by the development of pneumonia (MSCT I – II) with uncommon lung involvement. As a basic therapy, as well as pregnant women, they were prescribed high doses of recombinant interferon α-2b and β-lactam antibiotic to prevent aggravation of the condition. This therapy made it possible to avoid complications and stop the symptoms of damage to the bronchial tree. |
| format | Article |
| id | doaj-art-71b59bf723414a248c8fbb9a2903793e |
| institution | Kabale University |
| issn | 1560-5175 2687-1181 |
| language | Russian |
| publishDate | 2021-06-01 |
| publisher | Open Systems Publication |
| record_format | Article |
| series | Лечащий Врач |
| spelling | doaj-art-71b59bf723414a248c8fbb9a2903793e2025-08-20T03:57:51ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812021-06-0108717610.26295/OS.2020.35.14.012177Outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating womenA. V. Mordyk0L. V. Puzyreva1K. Yu. Samsonov2N. V. Bagisheva3Federal State Budgetary Educational Institution of Higher Education, Omsk State Medical University of the Healthcare Ministry of the Russian FederationFederal State Budgetary Educational Institution of Higher Education, Omsk State Medical University of the Healthcare Ministry of the Russian FederationFederal State Budgetary Educational Institution of Higher Education, Omsk State Medical University of the Healthcare Ministry of the Russian FederationFederal State Budgetary Educational Institution of Higher Education, Omsk State Medical University of the Healthcare Ministry of the Russian FederationThe problem of treating the new coronavirus infection COVID-19 in pregnant and lactating women is an urgent problem of world health. According to foreign authors (Mantlo E., Bukreyeva N., Maruyama J., Paessler S., Huang C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antiviral Res. 2020 Jul; 179: 104811) recombinant interferon α is active against the novel coronavirus in vitro in the cell culture model Vero and SARS-CoV-2 (COVID-19). SARS-CoV-2 (COVID-19) is sensitive to recombinant interferon α-2b, but high serum concentrations (more than 300 IU / ml) are required to achieve a therapeutic effect, which are achieved with systemic administration of more than 3,000,000 IU of recombinant interferon α -2b. The article analyzes the clinical symptoms and the effectiveness of therapy for the new coronavirus infection COVID-19 in pregnant and lactating women in outpatient practice with high doses of interferon α-2b (by the decision of the council of doctors). The authors found that complex therapy with high doses of interferon α-2b infection COVID-19 in pregnant women flows relatively favorably and ends with recovery. In lactating women who do not work because of parental leave, the new coronavirus infection had mild clinical symptoms and was accompanied by the development of pneumonia (MSCT I – II) with uncommon lung involvement. As a basic therapy, as well as pregnant women, they were prescribed high doses of recombinant interferon α-2b and β-lactam antibiotic to prevent aggravation of the condition. This therapy made it possible to avoid complications and stop the symptoms of damage to the bronchial tree.https://journal.lvrach.ru/jour/article/view/178pregnant womenlactating womeninterferon α-2bcovid-19β-lactam antibioticoutpatient therapy |
| spellingShingle | A. V. Mordyk L. V. Puzyreva K. Yu. Samsonov N. V. Bagisheva Outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating women Лечащий Врач pregnant women lactating women interferon α-2b covid-19 β-lactam antibiotic outpatient therapy |
| title | Outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating women |
| title_full | Outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating women |
| title_fullStr | Outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating women |
| title_full_unstemmed | Outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating women |
| title_short | Outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating women |
| title_sort | outpatient approaches to the treatment of novel coronavirus infection in pregnant and lactating women |
| topic | pregnant women lactating women interferon α-2b covid-19 β-lactam antibiotic outpatient therapy |
| url | https://journal.lvrach.ru/jour/article/view/178 |
| work_keys_str_mv | AT avmordyk outpatientapproachestothetreatmentofnovelcoronavirusinfectioninpregnantandlactatingwomen AT lvpuzyreva outpatientapproachestothetreatmentofnovelcoronavirusinfectioninpregnantandlactatingwomen AT kyusamsonov outpatientapproachestothetreatmentofnovelcoronavirusinfectioninpregnantandlactatingwomen AT nvbagisheva outpatientapproachestothetreatmentofnovelcoronavirusinfectioninpregnantandlactatingwomen |